Roche set to fully acquire Flatiron Health in $1.9bn deal to accelerate cancer drug development
Roche, the Swiss pharmaceutical giant, has announced its plans to fully acquire Flatiron Health, a leading oncology software company, for $1.9 billion. This strategic move aims to fast-track the development of cancer treatments by leveraging Flatiron Health’s advanced data analytics and electronic health records software. Strategic Expansion in Oncology The acquisition marks a significant step […]